Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Why Index Levels Matter explains the impact of index readings on market perception and strategy, guiding you to smarter investment choices.
23,403 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Jonathan Clements changed how everyday investors think about money. In this MiB-inspired reflection, Jason Zweig and ...
Got $1,000 to invest? This article outlines a real-world plan, explains why Nvidia makes sense before Micron, and giv...
The tech hand over fist craze can pull even careful investors into hype. This article lays out a practical plan: choo...
Anthropic, the Claude-maker, confidentially files to go public, igniting talk of a potential trillion-dollar valuatio...
Stocks wavered as the Nasdaq led declines ahead of key tech earnings after the bell. Learn what moved markets, how to...
Delve into the investing philosophy of Bill Miller IV, the CIO and PM behind Miller Value Fund. Learn how high-convic...
Berkshire Hathaway made some notable portfolio shifts that surprised many investors. This guide explains what happene...
A notable fund trimmed its stake in Core Scientific while the stock jumped dramatically. This article breaks down wha...
If you rely on Social Security, the 2027 COLA forecast isn't just a number—it's a planning tool. This article breaks ...
Prospect Capital offers a striking 20%+ yield, but its long-run performance raises questions. This article lays out a...
A stronger-than-expected jobs report unleashed a broad market selloff, wiping $1.4 trillion from S&P 500 valuations a...